thederrick.com

Fast chargers are expanding quickly, but American EV drivers still fear running out of juice

A new poll finds that many Americans remain hesitant to buy electric vehicles. The AP-NORC/EPIC poll found only about 2 in 10 ...

Biocon Biologics And Civica Team To Launch Private-Label Insulin Glargine In The U.S.

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

Novo Nordisk’s New Insulin Study: A Potential Game-Changer for Diabetes Management

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Healio

New-onset type 1 diabetes risk higher for young people with autoimmune disease

Adolescents and young adults with preexisting autoimmune disease are more likely to develop type 1 diabetes than those ...
The Lancet

Dual incretin therapy for type 2 diabetes inadequately controlled on basal insulin in Chinese adults: clinical and research implications

Băi wén bù rú yī jiàn“Seeing for oneself is a hundred times better than hearing from others.”Chinese Proverb from the Book of ...